In contrary, SphK2 deletion attenuated HUS disease severity, as evidenced primarily by the prevention of severe proximal tubule damage, the renal infiltration of macrophages, and kidney dysfunction. The gene discussed is SPHK2; the disease is hemolytic-uremic syndrome.